Innate Pharma (IPHYF) Shares Outstanding (Weighted Average) (2018 - 2025)
Historic Shares Outstanding (Weighted Average) for Innate Pharma (IPHYF) over the last 8 years, with Q2 2025 value amounting to $282.99.
- Innate Pharma's Shares Outstanding (Weighted Average) fell 1523.07% to $282.99 in Q2 2025 from the same period last year, while for Jun 2025 it was $282.99, marking a year-over-year decrease of 1523.07%. This contributed to the annual value of $86.6 million for FY2024, which is 5.68% up from last year.
- Per Innate Pharma's latest filing, its Shares Outstanding (Weighted Average) stood at $282.99 for Q2 2025, which was down 1523.07% from $86.6 million recorded in Q4 2024.
- In the past 5 years, Innate Pharma's Shares Outstanding (Weighted Average) ranged from a high of $91.0 million in Q4 2021 and a low of $21.78 during Q2 2023
- In the last 5 years, Innate Pharma's Shares Outstanding (Weighted Average) had a median value of $361.28 in 2021 and averaged $38.4 million.
- In the last 5 years, Innate Pharma's Shares Outstanding (Weighted Average) plummeted by 7637.17% in 2022 and then skyrocketed by 143286.68% in 2024.
- Over the past 5 years, Innate Pharma's Shares Outstanding (Weighted Average) (Quarter) stood at $91.0 million in 2021, then dropped by 10.71% to $81.3 million in 2022, then rose by 6.54% to $86.6 million in 2023, then rose by 0.06% to $86.6 million in 2024, then tumbled by 100.0% to $282.99 in 2025.
- Its Shares Outstanding (Weighted Average) was $282.99 in Q2 2025, compared to $86.6 million in Q4 2024 and $333.84 in Q2 2024.